Kantum is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. This targeted therapy will be supported by the development of a diagnostic test for AKI.
Company (Alive / Active)
75 S Main St #7-160
New Hampshire, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)